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Background: Attentional deficits are described in the
consensus clinical criteria for the operationalized diag-
nosis of dementia with Lewy bodies (DLB) as character-
istic of the condition. In addition, preliminary studies have
indicated that both attentional impairments and fluctua-
tion of attentional impairments are more marked in pa-
tients with DLB than in patients with Alzheimer disease
(AD), although neuropsychological function has not pre-
viously been examined in a large prospective cohort with
confirmed diagnostic accuracy against postmortem di-
agnosis.
Methods: A detailed evaluation of attention and fluc-
tuating attention was undertaken in 155 patients with de-
mentia (85 with DLB and 80 with AD) from a represen-
tative hospital dementia case register and 35 elderly
controls using the Cognitive Drug Research Computer-
ized Assessment System for Dementia Patients comput-
erized neuropsychological battery. Operationalized clini-
cal diagnosis was made using the consensus criteria for
DLB and the National Institute of Neurological and Com-
municative Disorders and Stroke–Alzheimer’s Disease and
Related Disorders Association criteria for AD. High lev-
els of sensitivity and specificity have been achieved for
the first 50 cases undergoing postmortem examination.
Results: The groups were well matched for severity of
cognitive impairments, but the AD patients were older
(mean age, 80 vs 78 years) and more likely to be female
(55% vs 40%). Patients with DLB were significantly more
impaired than patients with AD on all measures of at-
tention and fluctuating attention (for all comparisons,
t ‡ 2.5, P,.001), and patients from both dementia groups
were significantly more impaired than elderly controls
for all comparisons other than cognitive reaction time,
which was significantly more impaired in DLB patients
than controls but was comparable in controls and AD pa-
tients. There were, however, significant associations be-
tween the severity of cognitive impairment and the se-
verity of both attentional deficits and fluctuations in
attention.
Conclusions: This large prospective study confirms that
slowing of cognitive processing, attention, and fluctua-
tions of attention are significantly more pronounced in
DLB and AD patients, although fluctuating attention is
common in patients with moderate-to-severe AD. Defi-
cits of cognitive reaction time appear to be specific to DLB,
except in severe dementia. A detailed evaluation of at-
tentional performance could make an important contri-
bution to differential diagnosis, although the results need
to be interpreted within the context of the overall sever-
ity of cognitive deficits.
Arch Neurol. 2001;58:977-982
L EWY BODIES are intraneuro-nal eosinophilic inclusionbodies that are seen in thebrainstem and cortex of pa-tients with Parkinson dis-
ease and some patients with dementia.
Studies1-6 have suggested that dementia
with Lewy bodies (DLB) accounts for 10%
to 25% of dementia cases in clinical popu-
lations. An international meeting in 1996
developed operationalized clinical diag-
nostic criteria7; key features included fluc-
tuating cognition associated with distur-
bances of consciousness, persistent or
recurrent visual hallucinations, and par-
kinsonism. Early and pronounced impair-
ments were described as characteristic and
thought to underpin fluctuating cogni-
tion, although there have been few em-
pirical studies in this area. The complex
array of neuropsychiatric, motor, and cog-
nitive deficits and the extreme sensitivity
reactions to neuroleptic drugs experi-
enced by DLB patients raise a number of
vital treatment issues that can only be man-
aged optimally with accurate diagnostic as-
signment.7 In most studies examining the
clinical criteria for the operationalized di-
agnosis of DLB, the specificity of diagno-
sis has been high, but sensitivity has been
poor.8 There have been a paucity of stud-
ies examining the neuropsychological pro-
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file of DLB and the contribution of neuropsychological
evaluation to the diagnostic workup. Expert opinion has
highlighted attentional deficits as a key area in DLB,7 al-
though the empirical evidence base is small.
Hansen et al1 compared 9 patients with DLB with 9
patients with AD. More severe deficits of attentional func-
tion(digitspansubtest fromtheWechslerAdult Intelligence
Scale–Revised) were seen in DLB. Sahgal et al9 reported
that DLB patients had significantly greater impairment on
a computerized delayed matching-to-sample task. Ayre et
al10,11 used the Cognitive Drug Research Computerized As-
sessment System for Dementia Patients (COGDRAS-D)
computerized test battery12 to compare attention in 46
patients with AD and 24 patients with DLB. The DLB
group performed significantly worse on simple reaction
time (SRT) and choice reaction time (CRT) tasks and digit
vigilance (VIG) compared with the AD group.
The overall pattern is consistent, with DLB pa-
tients showing significantly greater impairment on a range
of attentional tasks. However, each of these studies is mod-
est in size, none including more than 24 patients with
DLB, and few had verified accuracy of clinical diagno-
sis. A larger study, from a cohort with confirmed diag-
nostic accuracy, is required to confirm the pattern of
attentional deficits in DLB.
Fluctuating cognition occurs in all the major demen-
tias and is characterized by periodic shifts in the level of
arousal, ranging from episodes of lucidity to reduced aware-
ness and even stupor. Fluctuating cognition occurs in 80%
to 90% of patients with DLB13,14 and in 20% of patients with
AD.15,16 Prevalence rates of 30% to 50% are also reported
in vascular dementia.17,18 Consistent with expert opinion,
Walker et al19 identified a significant association between
fluctuating cognition and fluctuating attention, both of
which were significantly more severe in DLB than AD
patients.
We investigated the hypothesis that attention and
fluctuating attention are significantly more impaired
in DLB than AD patients in a large representative
patient sample, with confirmed diagnostic accuracy.
SUBJECTS AND METHODS
The study sample consists of 155 dementia subjects (85 with
DLB, 80 with AD) and 35 elderly controls. Patients were re-
cruited from a dementia case register of consecutive refer-
rals to old age psychiatry services in Tyneside, England, with
spouses of patients recruited as healthy elderly volunteers.
Good diagnostic accuracy has been achieved for the first 50
patientsundergoingpostmortemexamination fromthesample
of 338 individuals within the overall case register (DLB: sen-
sitivity, 0.83; specificity, 0.91; AD: sensitivity, 0.87; specific-
ity, 0.8320). Patients with dementia were matched for the se-
verity of cognitive impairment using the Mini-Mental State
Examination (MMSE).21 All patients were assessed with a
structured psychiatric history (history and etiology sched-
ule22), a standardized physical examination that incorpo-
rated the modified Unified Parkinson’s Disease Rating Scale
(M-UPDRS),23 and a validated instrument to evaluate symp-
toms of depression (Cornell Depression Scale,24 which in con-
junction with questions regarding impact and duration of
symptoms was used to diagnose major depression accord-
ing to Diagnostic and Statistical Manual of Mental Disorders,
Revised Third Edition25 criteria). Dementia with Lewy bodies
was diagnosed according to the internationally agreed con-
sensus criteria7 and AD was diagnosed according to Na-
tional Institute of Neurological and Communicative Disor-
ders and Stroke–Alzheimer’s Disease and Related Disorders
Association criteria.26
The Joint Ethics Committee of Newcastle and North
Tyneside Health Authority University of Newcastle Upon
Tyne granted ethical approval. Following full explanation
and discussion of the study, patients and healthy volun-
teers gave their consent to the test, with additional assent
from the next of kin for all cognitively impaired patients.
NEUROPSYCHOLOGICAL EVALUATIONS OF
ATTENTION AND FLUCTUATING ATTENTION
Subjects were assessed using the COGDRAS-D.12 Atten-
tional tasks included the following: SRT (20 trials), each
time “yes” was presented in the center of the screen, the
participant was required to press the “yes” button as quickly
as possible; CRT (30 trials), each time “yes” or “no” was
presented in the center of the screen, the participant was
required to press the corresponding “yes” or “no” button
as quickly as possible (accuracy and reaction time mea-
sures were derived); cognitive reaction time (CogRT), cal-
culated by subtracting the SRT from the CRT; VIG (90 tri-
als), a digit was displayed constantly on the right-hand side
of the screen (VIGRT) and 90 digits were serially pre-
sented (80 min−1) in the middle of the screen; participants
were required to press “yes” every time that digit matched
the digit constantly displayed on the right side of the screen.
Within-trial variability (SD in the attentional mea-
sures of CRT) and an overall measure of attentional vari-
ability (CRT SD3VIGRT SD) were assessed in single tri-
als, all lasting approximately 90 seconds.
STATISTICAL ANALYSIS
The mean scores and the measures of variability on the at-
tentional tasks were compared between DLB and AD pa-
tients and between both dementia groups and controls us-
ing the independent sample t test. The same evaluation was
completed separately to compare DLB and AD patients with
MMSE scores greater than 20 to provide additional informa-
tion regarding differences in attentional performance and pro-
cessing speed in patients with mild dementia. The pattern of
change in attentional performance with increasing cogni-
tive impairment is described and evaluated with pairwise cor-
relations using the Pearson multivariate correlation coeffi-
cient (R). All of these evaluations were completed for the
overall group and separately, excluding patients who did not
attain 50% accuracy on the respective CRT or VIG tasks. Both
parkinsonism and depression were considered to be poten-
tially important confounders. The correlation between the M-
UPDRS score and each of the attentional measures was evalu-
ated using Pearson multivariate correlation coefficient, and
patients with and without major depression were compared
using the 2-sample t test. Data were analyzed using the SPSS
computer software program.27
(REPRINTED) ARCH NEUROL / VOL 58, JUNE 2001 WWW.ARCHNEUROL.COM
978
©2001 American Medical Association. All rights reserved.
RESULTS
One hundred fifty-five patients (85 with DLB: 40% fe-
male; mean±SD age, 78.0±6.3 years; mean±SD MMSE
score, 17.3 ±4.6; 80 with AD: 55% female; mean±SD age,
79.3±6.8 years; mean±SD MMSE score, 17.3±4.6) and
35 elderly controls (71% female; mean±SD age, 73.9±7.4
years; mean±SD MMSE score, 28.3±1.2) were assessed.
The DLB patients were significantly more impaired
than the AD patients on all tests of attention and fluctu-
ating attention. In a repeat analysis excluding patients
with less than 50% accuracy on the respective CRT or
VIG tasks, differences between the VIGRT of patients with
the 2 dementias disappeared, but the DLB patients were
more impaired on all of the other tasks (Table 1). Both
dementia groups were significantly more impaired on SRT,
CRT, VIG, and all measures of attentional variability than
the elderly controls. Cognitive reaction time was, how-
ever, significantly more impaired in DLB patients than
controls, but was not significantly more impaired in those
with AD than the control group (Table 1), indicating that
impairment of CogRT was specific to DLB.
The M-UPDRS score was inversely correlated with
VIG accuracy (R=−0.26, P=.04), but there were no sig-
nificant correlations with any of the other parameters (SRT
R=0.16, P=.22, SRT SD R=0.16, P=.21, VIGRT R=0.24,
P=.06, VIG SD R=0.08, P=.55, CRT accuracy R=−0.14,
P=.28, CRT R=0.19, P=.13, CRT SD R=0.16, P=.22,
CogRT R=0.11, P=.45). Major depression was not sig-
nificantly associated with any of the measures (SRT t=0.4,
P=.70, SRT SD t=0.6, P=.58, VIG accuracy t=0.1, P=.92,
VIGRT t=0.3, P=.79, VIG SD t=0.6, P=.53, CRT accu-
racy t=0.7, P=.47, CRT t=0.5, P=.64, CRT SD t=0.5,
P=0.67, CogRT t=0.1, P=.93).
In both DLB and AD, most measures of attentional
performance and most indices of fluctuating attention
were significantly correlated to the MMSE score. This ef-
fect was still apparent on CRT tasks among DLB pa-
tients when excluding the group with poor accuracy
(,50%), although it was attenuated to some extent for
CRT variability in AD patients with good levels of accu-
racy (Table 2). In both DLB (R=0.21, P=.11) and AD
(R=0.13, P=.29), however, there were no significant cor-
relations between MMSE and CogRT.
Table 1. Attention and Variability in Attention: Comparison of DLB and AD*
DLB (n = 85) vs
AD (n = 80) Overall
DLB (CRT n = 75,
VIG n = 52)
vs AD (CRT n = 74,
VIG n = 68)†
DLB vs Controls
(n = 36)
AD vs Controls
(n = 36)
t P t P t P t P
SRT 3.5 ,.001 . . . . . . 6.6 ,.001 6.6 ,.001
SRT variability 4.0 ,.001 . . . . . . 5.7 ,.001 5.2 ,.001
VIG accuracy 5.8 ,.001 . . . . . . 11.1 ,.001 5.5 ,.001
VIG reaction time 5.9 ,.001 1.6 .10 7.5 ,.001 6.7 ,.001
VIG reaction time variability 3.7 ,.001 3.4 ,.001 8.4 ,.001 7.5 ,.001
CRT 4.0 ,.001 3.7 ,.001 6.1 ,.001 6.1 ,.001
CRT variability 4.0 ,.001 3.8 ,.001 6.0 ,.001 2.6 .01
Cognitive reaction time 2.7 ,.001 2.3 .02 3.1 .003 0.2 .84
CRT accuracy 4.4 ,.001 . . . . . . 4.2 ,.001 2.3 .03
VIG 3 CRT variability 3.6 ,.001 3.0 .003 4.5 ,.001 3.2 .002
*DLB indicates dementia with Lewy bodies; AD, Alzheimer disease; CRT, choice reaction time; VIG, vigilance; SRT, simple reaction time; and ellipses, not
applicable.
†Excluding patients with poor accuracy.
Table 2. Correlations Between Specific Measures of Attention and Processing Speed and Mini-Mental State Examination Score*
DLB Overall
(n = 85)
AD Overall
(n = 80)
DLB With Good Accuracy
(CRT n = 75, VIG n = 52)
AD With Good Accuracy
(CRT n = 74, VIG n = 68)
R P R P R P R P
SRT −0.42 .001 −0.22 .06 . . . . . . . . . . . .
SRT variability −0.38 .004 −0.38 .001 . . . . . . . . . . . .
VIG accuracy −0.35 .009 −0.31 .008 . . . . . . . . . . . .
VIG reaction time 0.09 .52 −0.11 .35 0.12 .48 −0.22 .08
VIG reaction time variability −0.34 .001 −0.13 .27 −0.38 .02 −0.23 .06
CRT −0.43 .001 −0.43 ,.001 −0.41 .003 −0.29 .01
CRT variability 0.36 .007 −0.39 ,.001 −0.40 .004 −0.26 .03
Cognitive reaction time −0.21 .11 −0.13 .29 −0.19 .19 −0.13 .27
CRT accuracy −0.27 .04 −0.11 .36 −0.38 .006 . . . . . .
*DLB indicates dementia with Lewy bodies; AD, Alzheimer disease; CRT, choice reaction time; VIG, vigilance; SRT, simple reaction time; and ellipses, not
applicable. Good accuracy is more than 50% accuracy on choice reaction time tasks.
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The severity and fluctuation of attentional impair-
ments are particularly pronounced in DLB patients with
MMSE scores of 10 or less, even excluding patients with
poor levels of accuracy (,50%). It should, however, be
noted that the differences between DLB patients with
MMSE scores greater than 20 and AD patients with MMSE
scores of 10 or less were rather modest for most catego-
ries of symptoms. Cognitive reaction time was similar in
AD patients with MMSE scores of more than 10 and con-
trols, but became more comparable to DLB values in the
patients with the lowest MMSE scores (Figure 1 and
Figure 2). Statistical comparisons between the DLB
(n=15) and AD (n=15) patients with MMSE scores greater
than 20 indicated significant differences in VIG accu-
racy (t=2.4, P=.02), CRT (t=2.4, P=.02), and CRT vari-
ability (t=2.6, P=0.01) despite the small sample size.
COMMENT
The present study confirms that attentional deficits and
fluctuations in attention are substantially more severe in
DLB patients than in those with AD, even excluding
patients with poor levels of accuracy, and that both
dementia groups have greater overall attentional impair-
ments than elderly controls. A number of other factors,
such as parkinsonism with slowed motor speed, depres-
sion, or general slowing of cognitive processing speed,
could theoretically have contributed to these findings.
The data evaluation did not, however, indicate that
either motor speed or mood was a major confounder.
The general slowing of reaction times could certainly
imply a slowing of cognitive processing, although the
broad deficits CRT and VIG accuracy and reaction times
indicate a more widespread impairment of attentional
processing.
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Figure 1. Reaction times (in milliseconds): relationship with severity of
cognitive impairment. MMSE indicates Mini-Mental State Examination;
SEV.GA, severe dementia (MMSE score ,10) with good accuracy (.50%);
DLB, dementia with Lewy bodies; and AD, Alzheimer disease. For DLB
patients, n=84 (MMSE scores ,11, n=8; MMSE score of 11-20, n=61;
MMSE score .20, n=15); for AD patients, n=75 (MMSE scores ,11, n=6;
MMSE score of 11-20, n=54; MMSE score .20, n=15); and for control
patients, n=35.
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Figure 2. Choice reaction time, accuracy, and vigilance accuracy. MMSE
indicates Mini-Mental State Examination; DLB, dementia with Lewy bodies;
and AD, Alzheimer disease. For DLB patients, n=84 (MMSE scores ,11,
n=8; MMSE score of 11-20, n=61; MMSE score .20, n=15); for AD
patients, n=75 (MMSE scores ,11, n=6; MMSE score of 11-20, n=54;
MMSE score .20, n=15); and for control patients, n=35.
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Cognitive reaction time was the only attentional mea-
sure that was impaired in DLB patients compared with
controls, but it did not differ significantly between con-
trols and AD patients. Cognitive reaction time is a means
of studying the information processing requirements while
controlling for perceptuomotor dysfunction. Our find-
ings indicate the possibility that slowed “central process-
ing speed” is a specific neuropsychological feature of DLB,
which is not apparent in AD patients with MMSE scores
of more than 10. Between-group differences may have
been underestimated, since the marked increase of SRT
in DLB patients with severe dementia may have skewed
the calculation of CogRT in some patients.
The pattern of change of variability in SRT and CRT
tasks with increasing severity of dementia also indi-
cated important differences between the 2 dementias. Vari-
ability in reaction time increased dramatically with in-
creased cognitive impairment in the DLB patients, but
remained fairly static at all levels of impairment in the
patients with AD. This supports the hypothesis that fluc-
tuating attention is characteristic of DLB.7
In the present study, a standardized computerized
battery of attentional tasks was successfully completed
by the study participants, who included a number of
people with MMSE scores below 10; however, within this
more impaired group care needs to be taken when in-
terpreting the information from patients with poor lev-
els of accuracy. This battery can be completed in 15 min-
utes and appears highly suitable for use in clinical practice.
In addition, it clearly has sufficient sensitivity to distin-
guish among different dementia groups, even in mildly
impaired patients. The highly significant differences in
attentional performance between DLB and AD patients
suggest that detailed neuropsychology could provide an
important component of the diagnostic workup, al-
though the significant correlation between attentional per-
formance and overall MMSE score emphasize the need
to interpret the results within the context of the overall
severity of cognitive impairment for most attentional mea-
sures. This relationship diminished to some extent in AD
patients when those with poor levels of accuracy were
excluded, except for CRT, which remained significantly
correlated to MMSE score. Even focusing on DLB pa-
tients with good levels of accuracy, a strong relation-
ship to MMSE scores was evident. The exception was
CogRT, which was independent of dementia severity in
both dementia groups. This finding is difficult to ex-
plain and may again be an artifact of the marked in-
crease in SRTs in patients with more severe dementia.
The results are also important in emphasizing that fluc-
tuations in attention are common among patients with
moderate-to-severe AD.
Both neuropsychological and clinical observations
strongly suggest that DLB patients experience great dif-
ficulty in sustaining attention. The key role of the cho-
linergic system in attention,28-30 fluctuating cognition (par-
ticularly attention), and disturbances of consciousness19
has been well documented.31 The results of the present
study support this hypothesis, with attentional deficits
arising in mild cases of DLB, where marked cholinergic
loss is an early feature,32 but not occurring until a much
more advanced stage of the AD, where severe choliner-
gic deficits are a late feature.33
Now that sensitive and practical tests are available,
further work using specific receptor ligands in in vivo
neuroimaging studies, detailed clinicopathological and
cliniconeurochemical correlations, and pharmacologi-
cal challenge can pinpoint more accurately the chemi-
cal systems of brain areas that are involved in different
aspects of attentional performance. Clearly, the role of
cholinesterase inhibitors will be important to investi-
gate in this regard.
CONCLUSIONS
Overall, slowed processing speed, attentional impair-
ments, and fluctuation in attentional impairments are sig-
nificantly more severe in DLB than AD patients. How-
ever, in both disease groups, deficits of attention become
more pronounced with increasing severity of the demen-
tia and hence need to be interpreted within the context
of overall cognitive deficits. If interpreted in this way, a
more detailed evaluation of attention can make an im-
portant contribution to the diagnostic assessment. Per-
haps most important, however, deficits of CogRT were
specific to DLB patients and were not associated with
global cognitive performance and hence should form a
core component of the neuropsychological evaluation of
these cases. It is also evident that fluctuations in cogni-
tion are common in moderate-to-severe AD.
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